A large cohort study found no significant association between migraines, their subtypes, or frequency and Parkinson disease (PD) risk in women 45 years and older, suggesting migraines may not contribute to...
A new randomized clinical trial found that psilocybin therapy reduced symptoms of depression in frontline clinicians affected by the COVID-19 pandemic, with effects lasting up to 6 months.
Brain age gap may be a potential biomarker for cognitive impairment, revealing that adults with sickle cell anemia and those from economically deprived backgrounds show signs of premature brain aging linked...
New research reveals that elevated serum neurofilament light chain levels correlate with both acute and chronic neurological damage in acute hepatic porphyria, offering clinicians a potential tool for...
Early out-of-bed mobilization enhanced mobility and functional independence in intensive care unit (ICU) patients with moderate-to-severe traumatic brain injury, while also reducing ICU stays and...
A study investigated the neural mechanisms behind aggressive behaviors in patients with Alzheimer disease and amnestic mild cognitive impairment, revealing distinct associations between brain activity and...
A study on mild cognitive impairment found that depression and agitation are linked to regional brain atrophy and faster cognitive decline, suggesting these symptoms may indicate a higher risk for...
Researchers analyzed patient data from the Alzheimer’s Disease in Down Syndrome study to determine the sex differences in Alzheimer-related neuropsychiatric symptomology among adults with Down syndrome. ...
Using data from the National Alzheimer’s Coordinating Center, a team of researchers investigated any correlations between neuropsychiatric and depressive symptoms at AD dementia diagnosis. Their findings...
